4.80
+0.085(+1.80%)
Currency In USD
| Previous Close | 4.8 |
| Open | 4.77 |
| Day High | 4.82 |
| Day Low | 4.6 |
| 52-Week High | 25 |
| 52-Week Low | 3.2 |
| Volume | 28,429 |
| Average Volume | 209,685 |
| Market Cap | 91.14M |
| PE | -1.94 |
| EPS | -2.47 |
| Moving Average 50 Days | 5.28 |
| Moving Average 200 Days | 6.48 |
| Change | -0.01 |
Data not available
NeOnc Technologies Awarded $2.5 Million in NIH STTR Grants to Advance NEO212 in Gliomas and Leukemia
GlobeNewswire Inc.
Aug 07, 2025 1:00 PM GMT
CALABASAS, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a multi–Phase 2 clinical-stage biotechnology company focused on breakthrough therapies for central nervous system (CNS) malignancies, today annou
NeOnc Technologies Featured on Yahoo Finance's Podcast Trader Talk: AI and Biotech Take on Brain Cancer
GlobeNewswire Inc.
Aug 04, 2025 1:00 PM GMT
CALABASAS, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a multi-phase 2 clinical-stage biotechnology company advancing transformative treatments for brain and central nervous system cancers, was featur
NeOnc Technologies Signs Definitive Agreement to Acquire AI, 3D, and Quantum Modeling IP Portfolio from Dr. Ishwar K. Puri; Appoints Him to Board of Directors
GlobeNewswire Inc.
Jul 30, 2025 1:00 PM GMT
CALABASAS, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a multi Phase 2 clinical-stage biotechnology company pioneering innovative treatments for brain cancers, is proud to announce the signing of a de